A Multicentre Study of the Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire for Pre-Exposure Prophylaxis (PREP) In Individuals at Potential Occupational Risk for Ebola Virus Exposure

重组埃博拉-扎伊尔水泡性口炎疫苗对有埃博拉病毒暴露潜在职业风险的个体进行暴露前预防 (PREP) 的免疫原性的多中心研究

• 批准号: 349359
• 负责人: Halperin Scott A
• 金额: --
• 依托单位: University of Manitoba
• 依托单位国家: 加拿大
• 项目类别: Directed Grant
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-05-01 至 2019-05-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=349359&lang=en
• 关键词: Clinical Trial; Ebola Virus; Infectious Disease; Outbreak; Vaccine

Researchers are conducting a study of the V920 Ebola vaccine in healthy adults who may be at ongoing risk of exposure to Ebola virus in order to assess how long vaccine protection lasts. This vaccine has already been tested in thousands of healthy partici

研究人员正在对健康成年人进行V920埃博拉疫苗的研究，这些人可能处于持续暴露于埃博拉病毒的风险中，以评估疫苗保护的持续时间。这种疫苗已经在数千名健康人身上进行了试验。